124 related articles for article (PubMed ID: 25742214)
1. Acamprosate, alcoholism, and abstinence.
Mason BJ
J Clin Psychiatry; 2015 Feb; 76(2):e224-5. PubMed ID: 25742214
[No Abstract] [Full Text] [Related]
2. Oral and long-acting injectable naltrexone: removal of boxed warning for hepatotoxicity.
Stoddard J; Zummo J
J Clin Psychiatry; 2015 Dec; 76(12):1695. PubMed ID: 26717532
[No Abstract] [Full Text] [Related]
3. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).
Higuchi S;
J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205
[TBL] [Abstract][Full Text] [Related]
4. [New treatment options for alcohol dependence].
Müller CA; Heinz A
MMW Fortschr Med; 2013 May; 155(8):63-5. PubMed ID: 24437142
[No Abstract] [Full Text] [Related]
5. [Psychosocial treatment plus drug prophylaxis. Fewer recurrences after alcohol withdrawal].
Smolka MN; Kiefer F; Mann K
MMW Fortschr Med; 2003 Sep; 145(35-36):45. PubMed ID: 14584210
[No Abstract] [Full Text] [Related]
6. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
7. [Advances in the treatment of alcohol dependence: pharmacological relapse prevention].
Smolka MN; Kiefer F; Mann K
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():65-9. PubMed ID: 15490769
[TBL] [Abstract][Full Text] [Related]
8. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
9. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacotherapy of alcohol dependence].
Soyka M
MMW Fortschr Med; 2008 May; 150 Suppl 2():22-4. PubMed ID: 18680838
[No Abstract] [Full Text] [Related]
11. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence.
de Sousa A; de Sousa A
Alcohol Alcohol; 2005; 40(6):545-8. PubMed ID: 16043433
[TBL] [Abstract][Full Text] [Related]
12. [Acamprosate--new preclinical research aspects].
Spanagel R; Mann K
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():61-4. PubMed ID: 15490768
[TBL] [Abstract][Full Text] [Related]
13. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.
Heyser CJ; Schulteis G; Durbin P; Koob GF
Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136
[TBL] [Abstract][Full Text] [Related]
14. [Alcohol--mechanism of action, interactions and treatment of alcohol abuse].
Korpi E; Seppälä T
Duodecim; 1998; 114(10):1029-36. PubMed ID: 11524777
[No Abstract] [Full Text] [Related]
15. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Bochenski M
Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
[TBL] [Abstract][Full Text] [Related]
16. The effect of placebo in the alcohol withdrawal state.
Lichtigfeld FJ; Gillman MA
Alcohol Alcohol; 1989; 24(2):109-12. PubMed ID: 2655625
[TBL] [Abstract][Full Text] [Related]
17. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy of substance dependence and withdrawal syndromes].
Walter M; Wiesbeck GA
Ther Umsch; 2009 Jun; 66(6):449-57. PubMed ID: 19496041
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.
Boeijinga PH; Parot P; Soufflet L; Landron F; Danel T; Gendre I; Muzet M; Demazières A; Luthringer R
Neuropsychobiology; 2004; 50(1):71-7. PubMed ID: 15179024
[TBL] [Abstract][Full Text] [Related]
20. [Autonomic withdrawal syndrome and a protracted course of the abstinence syndrome--ambulatory diagnosis and therapy].
Assmann G
Z Arztl Fortbild (Jena); 1989; 83(16):819-21. PubMed ID: 2686207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
